Amendment to Paid-in Capital Increase Details
씨엑스아이
900120
Signal Score
Historical Avg Return (5d)
+0.38%
Data Coverage
100%n=2330
Risk-adjusted indicator based on 2330 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Stock trading suspended from May 12, 2026
- • Capital reduction effective May 14, 2026
- • 5:1 Stock consolidation effective May 21, 2026
- • Last closing price before suspension: 391 KRW (adjusted for consolidation: 1,955 KRW)
- • Operating funds to be raised: 37,510,371.29 HKD (approx. 7.24B KRW)
AI Analysis Summary
CXI Healthcare Technology Group Limited filed an amendment to its Material Fact Report regarding a paid-in capital increase. The company's stock trading was suspended from May 12, 2026, due to a capital reduction effective May 14, 2026, and a 5:1 stock consolidation effective May 21, 2026. The new share issuance price will be based on the May 11, 2026, closing price of 391 KRW, adjusted to 1,955 KRW after consolidation. The company aims to raise 37,510,371.29 HKD (approximately 7.24 billion KRW) for operating funds, primarily for its overseas subsidiaries. The capital increase is a third-party allocation to the largest shareholder, with a 3-year lock-up period to mitigate dilution concerns. While dilution is a risk, the capital injection is intended to strengthen financial health and support business operations.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.